HL7v2 to CCD
April 22, 2014
Confused? Start with What You Know Over the past few months, we’ve heard a lot from our hospital-based customers about CCD and C-CDA readiness. There’s
Confused? Start with What You Know Over the past few months, we’ve heard a lot from our hospital-based customers about CCD and C-CDA readiness. There’s
Tip 6 in the Interoperability Tip Series This tip is for hospital or provider analysts and team leads. You’ve got a firm grasp of the
The Status Quo This is the world interface analysts, developers, and quality testers work in: 2 weeks to get a list of code values for
Tip 5 in the Interoperability Tip Series 9 Critical Questions You Need to Ask Your Clinical System and Interface Vendors Like our last two tips,
We’re excited! This is a major release for the entire Caristix platform with significant new features. Workgroup New Features Message Comparison: compare messages one-on-one. Do
A 16-minute Introduction to Caristix Workgroup: Part Six We’re wrapping up our Introduction to Workgroup with Part 6 (1:30 minutes) We designed this demo webinar
Tip 4 in the Interoperability Tip Series 5 Questions for HIT Vendors and Internal Interfacing Teams Like last week’s healthcare data interoperability tip, this week’s
A 16-minute Introduction to Caristix Workgroup: Part Five When you work with patient data, you need to be vigilant about protecting privacy. Caristix Workgroup software
Tip 3 in the Interoperability Tip Series Work in a health system or for a provider organization? This tip on healthcare data is especially important
A 16-minute Introduction to Caristix Workgroup: Part Four Ready for the next piece of our 16-minute webinar on Caristix Workgroup? Learn what Workgroup can do
NORTH AMERICA: +1 (877)-872-0027
WORLD: 1-418-872-4000
EMAIL: info@caristix.com
ASIA-PACIFIC
DENIS CANTIN
T: +61418441388
denis.cantin@caristix.com
NORTH AMERICA & EUROPE
JEAN-LUC MORIN
T: 418 872-4000
jeanluc.morin@caristix.com
HL7® / FHIR® are a registered trademarks of Health Level Seven International. The use of this trademark does not constitute an endorsement by HL7.